8 Wake Forest Intell. Prop. L.J. 407
This article explores the contrasts between the developed and developing worlds in their approach toward counterfeit pharmaceuticals and the issues raised by counterfeit pharmaceuticals in the developing world. Professor Cahoy proposes positive and negative incentives for private industry to help policy makers address the problem of counterfeit pharmaceuticals. Disincentives include tort liability for manufacturers of counterfeit drugs, while incentives would reward practices like granting subsidies to promote access to affordable and safe pharmaceuticals.